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1192Objective: The purpose of this longitudinal study was to assess improvements in exercise performance and
quality of life in patients with Ebstein anomaly after surgical intervention.
Methods: In 21 patients with Ebstein anomaly (between 6 and 59 years of age; 16 female, 5 male) who under-
went surgery for tricuspid regurgitation and, if present, closure of an interatrial shunt, a cardiopulmonary
exercise test and a quality-of-life assessment by the Medical Outcomes Study 36 item short form was performed
prior to and 6 to 18 months after surgery.
Results: After surgery, peak oxygen uptake increased from 68.4% of predicted to 77.3% of predicted
(P ¼ .009), and ventilatory efficiency (VE/VCO2 slope) improved from 32.5 to 29.3 (P ¼ .001). In 14 patients
with additional interatrial shunt closure, oxygen saturation improved from 95% to 99% at rest (P ¼ .003)
and from 88% to 99% under peak exercise (P¼ .003). Improvements in VE/VCO2 slope were similar in patients
who had undergone primary surgery (P¼ .005) or reoperation (P¼ .018). Increase in exercise capacity was also
similar in both groups but failed significance in both (primary surgery, P ¼ .064; reoperation, P ¼ .063). There
was no difference between tricuspid valve repair and replacement in the short-term follow-up. Self-estimated
quality of life was fairly good prior to and after surgery. Only in the single question about health transition at
follow-up did the patients confirm an improved situation after surgery.
Conclusions: Patients with Ebstein anomaly and severe tricuspid regurgitation draw clinical benefit from
surgical intervention as measured on exercise testing. This holds true for primary surgery and for reoperation.
(J Thorac Cardiovasc Surg 2011;141:1192-5)Ebstein anomaly is a rare congenital malformation occurring
in less than 1% of all cases of congenital heart defects. It is
characterized by the downward displacement of the tricuspid
valve into the right ventricle, reducing the effective right ven-
tricular volume, and by an enlarged redundant anterior leaflet
and the adherence of the septal and/or posterior leaflets to the
underlying myocardium. Tricuspid regurgitation and right
heart failure are the leading clinical findings. Its severity un-
derlies the various constellations of tricuspid malforma-
tion.1,2 An interatrial communication is present in 80% to
94% of patients with Ebstein anomaly.1-3 Most often this
is a patent foramen ovale that opens with increased right
atrial pressure. At least at exercise, these patients suffer
from cyanosis, dyspnea, and exercise intolerance caused by
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The Journal of Thoracic and Cardiovascular SurIn Ebstein anomaly, some patients with mild forms live
normal lifespans in good condition without surgery.
However, many other patients require surgery. The appro-
priate time for intervention remains unclear.5,6 On one
hand, early surgery at the age of 12 years or younger is
associated with earlier reoperation.5,7 On the other hand,
when functional status deteriorates because of an increase
in right-heart size, reduction in systolic function, and/or
increasing cyanosis, surgery is urgently indicated to pre-
serve right-ventricular function.1,5
Nowadays, cardiopulmonary exercise test (CPET) is the
keymethod for assessing functional status.8 Inmany centers
it is an important element, in addition to echocardiography
and magnetic resonance imaging, in determining the need
for surgery. Moreover, CPET is used to assess the benefit
of surgical intervention because CPET is a predictor of
long-term survival. This has been shown not only in healthy
people8 but also in patients with several other congenital
heart defects.9,10
Improvements in exercise tolerance after surgical inter-
vention have been suspected in mainly cross-sectional
reports that included only few longitudinal data.4,11,12
This study aimed to clarify, through a longitudinal study,
which patients draw the most clinical benefit from surgery
and whether this benefit is associated with an
improvement in quality of life.gery c May 2011
Abbreviation and Acronym
CPET ¼ cardiopulmonary exercise test





BetweenMarch 2002 and October 2009, 21 patients with Ebstein anom-
aly who had undergone surgery were included in the study. They took
a CPET and a quality-of-life assessment prior to surgery and the same
examinations after surgery; the median time interval was 12.4 months
(6.5-17.9 months). Almost all of them had moderate or severe tricuspid re-
gurgitation, both clinically and on echocardiography (Table 1).
Of the 21, 14 underwent primary surgery of the tricuspid valve (group 1).
In 10 of these patients, valve repair was performed; in the other 4, replace-
ment with a biological valvewas performed. In 11 patients with atrial septal
defect or patent foramen ovale, the defect was closed in one session.
Of the other patients, 7 had already undergone a previous surgical inter-
vention for Ebstein anomaly (group 2). In the prior operation all of them
had had repair of the tricuspid valve and closure of the interatrial shunt.
At reoperation, repair of the valve could be achieved in only 2 patients.
In the other 5 patients, the valve was replaced by a biological valve
prosthesis.
The criteria for surgery were moderate or severe tricuspid regurgitation;
diminished right ventricular function as seen in magnetic resonance imag-
ing; decrease in exercise capacity; severity of cyanosis; and subjective
perception of well-being. After discussing those criteria carefully with doc-
tors, surgeons, and the patients, a consensus decision was made.
Surgical procedures included several techniques, depending on the sur-
geon’s preference: Alfieri stitch, DeVega annuloplasty, Sebening stitch, or
valve replacement.
The study was done in accordance with the declaration of Helsinki (re-
vision 2008). Patients agreed to the anonymous publication of their data.
Some of the patients had already been included in previous reports from
our group.13,14
Cardiopulmonary Exercise Test
All patients underwent a symptom-limited CPETon a bicycle in upright
position, as previously reported.15
After a 3-minute rest to define baseline, patients had a 3-minutewarmup
without load, followed by a rampwise increase of load with 5, 10, 15, or
20 W per minute, depending on the expected individual physical capacity
estimated by the investigator. The aim was to reach a cycling time of about
8 to 12 minutes after warmup. The end of the CPETwas marked by symp-
tom limitation and was followed by a 5-minute recovery period, with the
first 2 to 3 minutes cycling with minimal load.TABLE 1. Changes in CPET: Comparing Baseline Testing with Follow-up
Bas
Sex _/\
Age Years 24.5 (1
Tricuspid regurgitation I/II/III/IV 0 / 2 /
RER Peak 1.07 (1
SpO2y (%) Rest 98 (9
Peak 92 (8
Peak VO2 mL/min/kg 21.0 (1
% of predicted 68.4 (5
VE/VCO2 Slope 32.5 (3
CPET, Cardiopulmonary exercise test; RER, respiratory exchange ratio. *2-sided Wilcoxo
The Journal of Thoracic and CarThe exercise test featured a breath-by-breath gas exchange analysis us-
ing a metabolic chart (Vmax 229; SensorMedics, Viasys Healthcare, Yorba
Linda, Calif). Peak oxygen uptake (VO2) was defined as the highest mean
uptake of any 30-second time interval during exercise. Reference values to
compute percentage of prediction were calculated as previously de-
scribed15 by Cooper and Weiler-Ravell16 for children less than 18 years
of age and by Cooper and Store17 for adults. Ventilatory efficiency was dis-
played as a VE/VCO2 slope confined to the linear part of the curve, exclud-
ing values beyond the ventilatory compensation point.
Quality of Life
Just before the exercise test, health-related quality of life was measured
using the Medical Outcomes Study 36-item short form (SF-36), as previ-
ously described.15 It has an acceptable internal consistency and has proven
useful in various medical specialties without any bias for symptoms of
a specific disease. The SF-36 measures 8 health constructs using 8 sub-
scales with 2 to 10 items per subscale and a single-item subscale of health
transition, describing subjective health changes over the past year (36 ques-
tions in all). Some of these subscales represent physical health, whereas
others, such as mental health, refer to real quality of life.
The German version of the self-report form, which has a window of 4
weeks, was used.18 Age- and sex-related reference values were extracted
from the German SF-36 evaluation study.19
Data Analyses
The data were skewed, so all descriptive data were expressed in median
values and interquartile ranges (Q1-Q3). Nonparametric Wilcoxon tests
were calculated to detect significant differences between parameters at
baseline and after surgical intervention. Afterward, primary operated and
reoperated patients were analyzed separately. The nonparametric Spear-
man correlation was used to find associations between baseline parameters
and changes in CPET parameters that would predict surgical outcome.
All analyses were performed using PASW Statistics 17.0 (SPSS, Inc.,
Chicago, Ill). P values < .05 in a 2-sided analysis were considered
significant.RESULTS
Exercise Capacity
At baseline testing, median age was 24.5 years (13.7-43.6
years) and peakVO2 was reduced to 21.0 (17.6-23.5) mL/kg/
min, representing 68.4% of predicted values (52.2%-
83.3% of predicted values).
After surgery, peak VO2 improved significantly (from
68.4% to 77.3%, P ¼ 0.009) as did the VE/VCO2 slope
(32.5 to 29.3; P ¼ 0.001) (Table 1). Moreover, oxygenAfter Surgical Intervention
eline test Follow-up P values*
5/16 5/16 –
3.7 – 43.6) 26.7 (14.8 – 44.9) –
16 / 3 9 / 10 / 2 / 0 < .001
.03 – 1.13) 1.07 (1.03 – 1.13) .501
5 – 99) 99 (97 – 100) .004
4 – 98) 97 (95 – 100) .010
7.6 – 23.5) 20.7 (18.8 – 27.9) .009
2.2 – 83.3) 77.3 (57.2 – 91.4) .009
0.3 – 43.8) 29.3 (27.8 – 33.1) .001
n test. ySpO2 could be assessed in only 20 patients.
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TABLE 2. Changes in CPET variables during follow-up by patients undergoing primary surgery and patients being reoperated
Primary surgery (group 1)
n ¼ 14, Median (Q1-Q3)
Reoperation (group 2)
n ¼ 7, Median (Q1-Q3)
Baseline test Follow-up P values* Baseline test Follow-up P values*
Sex _/\ 3/11 2/5 .557y
Age Years 18.3 (10.8–46.3) 31.1 (21.1–41.3) .224z
TR I/II/III/IV 0/2/11/4 5/8/1/0 .002 0/0/5/2 4/2/1/0 .014
RER Peak 1.04 (1.01–1.09) 1.04 (1.01–1.12) .248 1.12 (1.08–1.23) 1.10 (1.07–1.16) .672
SpO2 (%)x Rest 95 (92–98) 99 (99–100) .003 99 (98–100) 99 (98–100) .279
Peak 88 (78–94) 99 (97–100) .003 99 (98–100) 99 (98–100) .317
peak VO2 mL/min/kg 21.0 (17.8–22.1) 20.3 (18.5–27.8) .059 20.3 (16.4–24.1) 21.3 (18.5–29.5) .091
% predicted 68.8 (51.0–83.0) 77.8 (58.0–92.1) .064 56.4 (53.1–86.7) 73.6 (55.5–92.1) .063
VE/VCO2 Slope 32.3 (30.8–50.5) 29.4 (27.8–32.9) .005 32.5 (30.0–36) 29.3 (26.5–34.5) .018
CPET, Cardiopulmonary exercise test; RER, respiratory exchange ratio; TR, tricuspid regurgitation. *2-sided Wilcoxon test. yChi-squared test comparing the sex distribution of
the 2 subgroups. z2-sided Mann-Whitney-U test comparing the age of the 2 subgroups at baseline test. xSpO2 saturation could be assessed in only 20 patients.
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Dsaturation was significantly higher both at rest (P ¼ .004)
and at peak exercise (P ¼ .010).
Comparison of subgroups is displayed in Table 2. Only
the patients who had had primary surgery (group 1) showed
improvement in oxygen saturation both at rest and with
peak exercise. Improvement in the VE/VCO2 slope and exer-
cise capacity was similar in both groups after surgery.
Patients with higher VE/VCO2 slopes at baseline testing
showed the greatest improvement in VE/VCO2 slope values
after surgery (r ¼ -0.724; P<.001).
Improvements in CPET parameters showed no relation to
age, operation method (valve repair or replacement), body
mass, or body height.
Quality of Life
Self-estimated quality of life was fairly good. On several
scales, the best imaginable result was achieved in many pa-
tients both before and after surgery. Only in the dimension of
health transition, which asked a single question about health
changes during the past year, was a significantly better result
reported by the patients who had had surgery (baseline 50
[50-75] versus follow-up 75 [50-75]; P ¼ 0.014).
DISCUSSION
Our longitudinal study demonstrates a significant in-
crease in exercise performance after surgery for Ebstein
anomaly. We found a significant increase in peak VO2 and
an improvement in ventilatory efficiency depicted as
a VE/VCO2 slope after surgery. Moreover, cyanosis was
eliminated in patients who underwent primary surgery.
Driscoll and colleagues11 estimated a postoperative exer-
cise improvement in peak VO2 of about 25% of predicted
rates and the subsequent study by the same group, published
by MacLellan-Tobert and colleagues,4 found an increase of
14% of predicted rates. Additionally, oxygen saturation in-
creased sensationally in the postoperative group at rest and
under peak exercise in these 2 studies. However, these stud-
ies were cross-sectionally designed. The pre- and postoper-
ative group did not include the same subjects, making1194 The Journal of Thoracic and Cardiovascular Surstatistical analysis limited. Only 4, and in the later report
7, patients were tested twice. However, the increase in
peak VO2 of more than 25% of predicted rates and later
the increase of 14% of predicted rates were drawn from
all subjects included in the study. The later estimation is
closer to our data, showing an increase in peak VO2 of
more than 9% of predicted rates. The lower increase in
our cohort is related to our high baseline value of 68.4%
of predicted rates. This high baseline parameter relates to
a change in the policy of our institution. Augustin and col-
leagues20 related postoperative survival to functional class
and right-heart size. They concluded that a deteriorated
right ventricle, estimated as New York Heart Association
(NYHA) Stadium IV or a cardiothoracic ratio greater than
0.65 must be avoided in order to achieve a good postopera-
tive outcome. Using that background, it is important to de-
termine the right time in decline of exercise capacity and
shift from NYHA II to NYHA III to operate so as to prevent
further deterioration. This knowledge changed the opera-
tion policy in our institution in 2000; now we send patients
to surgery earlier, and that is reflected by the high baseline
values and the good clinical outcomes.
A more detailed analysis of our data shows that patients
seem to benefit from surgery in two ways. First, closure of
the interatrial shunt eliminated hypoxemia in those who
underwent primary surgery (group 1). This shunt closure
is expected to increase peak VO2 and to improve ventilatory
efficiency.21 However, improvements in tricuspid and
consecutive right-heart function is another substrate for
the improvement in exercise performance because patients
who had had previous surgery (group 2) showed a similar
increase in exercise capacity and also better ventilatory ef-
ficiency after tricuspid valve re-repair or biovalve implanta-
tion. The improvements in exercise capacity in the group as
a whole were not correlated with previous operation involv-
ing closure of or with any other baseline parameters. On the
contrary, persistence of severe tricuspid regurgitation with-
out an atrial septal defect or patent foramen ovale might ag-
gravate right-heart function and cause right-heart failuregery c May 2011
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Dand syncope at exercise, as is seen in patients with pulmo-
nary arterial hypertension without shunt.
Concordant with MacLellan-Tobert and colleagues,4 the
surgical technique (repair or replacement of the tricuspid
valve) had no influence on the surgical outcome in terms
of exercise performance. Moreover, and in coherence with
Driscoll and colleagues,11 age had no influence on the out-
come of exercise performance. Indeed, MacLellan-Tobert
and colleagues4 described a benefit in peak VO2 in younger
age groups, both preoperatively and postoperatively. How-
ever, this result matches that of the general population,
which also shows decreasing exercise capacity with age
that is not an effect of surgery.
Concerning quality of life, the better result in the dimen-
sion of health transition proves good postsurgical results in
terms of exercise; patients rated their health status as
improved over that of a year earlier. However, in the other
domains, self-estimated quality of life at baseline was fairly
good for most patients, making postoperative improvement
difficult. In the domains of physical roles, bodily pain,
social function, and emotional roles, the median results
had already reached the maximum, leaving no room for
improvement after surgery. In the other domains, only mar-
ginal changes were measured. In summary, these divergent
findings based on exercise testing and estimation of quality
of life at baseline emphasize our previously published
results—quality of life and even self-estimated physical
functioning do not follow actual exercise capacity.13,14
In conclusion, patients with Ebstein anomaly and severe
tricuspid regurgitation benefit from surgical intervention
regarding their exercise performance. This holds true for
primary surgery as well as for reoperations, so there are
good arguments in favor of early surgical repair.References
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